These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7036711)

  • 1. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress.
    Nagler J; Miskovitz P
    Am J Gastroenterol; 1981 Dec; 76(6):495-9. PubMed ID: 7036711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
    Maddern GJ; Kiroff GK; Leppard PI; Jamieson GG
    J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind crossover trial of domperidone in chronic postprandial dyspepsia.
    Englert W; Schlich D
    Postgrad Med J; 1979; 55 Suppl 1():28-9. PubMed ID: 382150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress.
    Haarmann K; Lebkuchner F; Widmann A; Kief W; Esslinger M
    Postgrad Med J; 1979; 55 Suppl 1():24-7. PubMed ID: 382149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making a case for domperidone in the treatment of gastrointestinal motility disorders.
    Ahmad N; Keith-Ferris J; Gooden E; Abell T
    Curr Opin Pharmacol; 2006 Dec; 6(6):571-6. PubMed ID: 16997628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domperidone: review of pharmacology and clinical applications in gastroenterology.
    Reddymasu SC; Soykan I; McCallum RW
    Am J Gastroenterol; 2007 Sep; 102(9):2036-45. PubMed ID: 17488253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
    Soykan I; Sarosiek I; Shifflett J; Wooten GF; McCallum RW
    Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
    Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Domperidone in the treatment of irritable colon. A placebo-controlled double-blind study].
    Fallingborg J; Christensen LA; Nielsen ST; Thommesen P; Jensen PF
    Ugeskr Laeger; 1987 May; 149(21):1390-2. PubMed ID: 3299950
    [No Abstract]   [Full Text] [Related]  

  • 13. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.
    Silvers D; Kipnes M; Broadstone V; Patterson D; Quigley EM; McCallum R; Leidy NK; Farup C; Liu Y; Joslyn A
    Clin Ther; 1998; 20(3):438-53. PubMed ID: 9663360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.
    Davis RH; Clench MH; Mathias JR
    Dig Dis Sci; 1988 Dec; 33(12):1505-11. PubMed ID: 3058442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe snoring with a combination of pseudoephedrine sulfate and domperidone.
    Larrain A; Hudson M; Dominitz JA; Pope CE
    J Clin Sleep Med; 2006 Jan; 2(1):21-5. PubMed ID: 17557432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis.
    Farup CE; Leidy NK; Murray M; Williams GR; Helbers L; Quigley EM
    Diabetes Care; 1998 Oct; 21(10):1699-706. PubMed ID: 9773734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit.
    Xie W; Xing D; Zhao Y; Su H; Meng Z; Chen Y; Du L
    Eur J Pharmacol; 2005 Mar; 510(1-2):113-20. PubMed ID: 15740731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Controlled Clinical Trial on Value of Domperidone in Functional Abdominal Pain in Children.
    Karunanayake A; Devanarayana NM; de Silva A; Gunawardena S; Rajindrajith S
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):725-731. PubMed ID: 29112086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
    Dumitrascu DL; Weinbeck M
    Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.